Flare Therapeutics and Roche Forge Strategic Partnership to Discover Precision Oncology Therapies Targeting Transcription Factors

FDA Approves Autolus’s CAR-T Therapy Aucatzyl for Relapsed or Refractory B-ALL in Adults

Biosimilars: Expanding Access to Precision Medicine through Affordable Biologic Therapies

IDEAYA Biosciences Secures Exclusive Worldwide License for Biocytogen’s BsADC Program IDE034 for Solid Tumor Treatment

Seer and Thermo Fisher Scientific Announce Strategic Collaboration to Advance Proteomics with Integrated Platform Solution

SystImmune Secures FDA Clearance for IND Application of Novel ADC Therapy BL-M17D1 for Advanced Solid Tumors

Medicare Expands Coverage for Adaptive Biotechnologies' clonoSEQ® MRD Test to Include Mantle Cell Lymphoma

Illumina and PHASE Partner to Advance Oncology Testing in the Greater Bay Area, Supporting the "Healthy China" Initiative

MGI Partners with Human Cell Atlas to Advance Global Human Cell Mapping

NHS Wales and Illumina Expand Partnership to Advance Genomic Cancer Detection and Personalized Medicine

Unlocking Genomic Potential for Rare Cancers: Cancer52 and Genomics England’s Collaborative Approach

Tempus AI Launches Immune Profile Score to Enhance Precision in Immunotherapy for Advanced Cancer Patients

Key Resources and Organizations for Precision Medicine Guidelines

MedGenome Strengthens Leadership Team to Drive North American Expansion in Precision Medicine

NCCN Expands Clinical Practice Guidelines for High-Risk Genetic Cancer Assessment

Home
/
update
/
details

MicrobioTx Launches Gut Function Test (GFT) for Easy, Affordable Gut Health Profiling

NextEdge Admin

07 Nov 2024

1 min 51 sec

Gut Function Test,personalized probiotic

MicrobioTx, a new-age gut microbiome company, has launched the Gut Function Test (GFT), a revolutionary way to profile the gut microbiome using only a few drops of blood, eliminating the need for traditional stool samples. Validated through clinical trials at prominent Indian institutes and recently approved by Indian regulators, this test enables easier access to essential gut health insights. Supported by a DPIIT grant, the GFT aims to make gut health monitoring accessible and affordable.

The test provides insights into the gut microbiome, which has been linked to better immunity, weight management, and overall health. MicrobioTx complements the GFT with consultation, food recommendations, and Personal ProbioTx, a personalized probiotic designed to address specific gut profiles.

According to Dr. Palok Aich, a microbiome expert, this innovative approach holds promise for transforming preventive health in India. Akanksha Gupta, co-founder of MicrobioTx, emphasized the convenience of the GFT, which addresses the challenges of stool-based tests such as cost, inconvenience, and long processing times. With a focus on translating microbiome research into practical healthcare solutions, MicrobioTx aims to expand its offerings for various health conditions and microbiome sites.